Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol HKT-500-US08: A Randomized, Multicenter, Double-blind, Placebo-controlled, Two-week Study to Assess the Efficacy and Safety of HKT-500 in Subjects With Acute Shoulder Pain

NCT00680472 is registered in ClinicalTrials.gov with Hisamitsu Pharmaceutical Co., Inc. as lead sponsor.

NCT NCT00680472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00680472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol HKT-500-US08: A Randomized, Multicenter, Double-blind, Placebo-controlled, Two-week Study to Assess the Efficacy and Safety of HKT-500 in Subjects With Acute Shoulder Pain
Lead sponsor
Hisamitsu Pharmaceutical Co., Inc.
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2008
Completion date
October 31, 2008
Enrollment
368 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

pain